Cargando…
Therapeutic effects of CO-releaser/Nrf2 activator hybrids (HYCOs) in the treatment of skin wound, psoriasis and multiple sclerosis
Carbon monoxide (CO) produced by heme oxygenase-1 (HO-1) or delivered by CO-releasing molecules (CO-RMs) exerts anti-inflammatory action, a feature also exhibited by the nuclear factor erythroid 2-related factor 2 (Nrf2), a master regulator of the stress response. We have recently developed new hybr...
Autores principales: | El Ali, Zeina, Ollivier, Anthony, Manin, Sylvie, Rivard, Michael, Motterlini, Roberto, Foresti, Roberta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7184182/ https://www.ncbi.nlm.nih.gov/pubmed/32335359 http://dx.doi.org/10.1016/j.redox.2020.101521 |
Ejemplares similares
-
HYCO-3, a dual CO-releaser/Nrf2 activator, reduces tissue inflammation in mice challenged with lipopolysaccharide
por: Motterlini, Roberto, et al.
Publicado: (2018) -
Increased Sirt1 secreted from visceral white adipose tissue is associated with improved glucose tolerance in obese Nrf2-deficient mice
por: Braud, Laura, et al.
Publicado: (2020) -
Hybrid Core-Shell (HyCoS) Nanoparticles produced by Complex Coacervation for Multimodal Applications
por: Vecchione, D., et al.
Publicado: (2017) -
Anti-inflammatory activities of carbon monoxide-releasing molecules (CO-RMs) in the brain
por: Motterlini, Roberto, et al.
Publicado: (2015) -
Emerging concepts on the anti-inflammatory actions of carbon monoxide-releasing molecules (CO-RMs)
por: Motterlini, Roberto, et al.
Publicado: (2012)